Published in FEBS Lett on October 14, 2010
Tuning of antigen sensitivity by T cell receptor-dependent negative feedback controls T cell effector function in inflamed tissues. Immunity (2014) 2.58
F-actin polymerization and retrograde flow drive sustained PLCγ1 signaling during T cell activation. J Cell Biol (2012) 1.64
The Serial Engagement Model 17 Years After: From TCR Triggering to Immunotherapy. Front Immunol (2012) 0.94
Barcoding T cell calcium response diversity with methods for automated and accurate analysis of cell signals (MAAACS). PLoS Comput Biol (2013) 0.92
Biomimetic particles as therapeutics. Trends Biotechnol (2015) 0.85
A stochastic T cell response criterion. J R Soc Interface (2012) 0.82
Cytoskeletal dynamics: concepts in measles virus replication and immunomodulation. Viruses (2011) 0.81
Receptor Pre-Clustering and T cell Responses: Insights into Molecular Mechanisms. Front Immunol (2014) 0.80
Experimental and theoretical bases for mechanisms of antigen discrimination by T cells. Biophysics (Nagoya-shi) (2015) 0.75
Dependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time. Immunity (2010) 2.82
WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells. J Exp Med (2007) 1.77
Inherited perforin and Fas mutations in a patient with autoimmune lymphoproliferative syndrome and lymphoma. N Engl J Med (2004) 1.72
A proportion of patients with lymphoma may harbor mutations of the perforin gene. Blood (2005) 1.54
T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. Proc Natl Acad Sci U S A (2005) 1.49
Defective Th1 cytokine gene transcription in CD4+ and CD8+ T cells from Wiskott-Aldrich syndrome patients. J Immunol (2006) 1.44
Evolution of virulence: interdependence, constraints, and selection using nested models. Theor Popul Biol (2005) 1.37
A hidden Markov model for single particle tracks quantifies dynamic interactions between LFA-1 and the actin cytoskeleton. PLoS Comput Biol (2009) 1.19
Optimizing within-host viral fitness: infected cell lifespan and virion production rate. J Theor Biol (2004) 1.18
Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models. Mol Ther (2009) 1.15
A role for rebinding in rapid and reliable T cell responses to antigen. PLoS Comput Biol (2009) 1.11
Blood leukocytes and macrophages of various phenotypes have distinct abilities to form podosomes and to migrate in 3D environments. Eur J Cell Biol (2012) 1.03
Mechanical force regulates integrin turnover in Drosophila in vivo. Nat Cell Biol (2012) 1.02
An initial and rapid step of lytic granule secretion precedes microtubule organizing center polarization at the cytotoxic T lymphocyte/target cell synapse. Proc Natl Acad Sci U S A (2013) 0.99
Modeling within-host evolution of HIV: mutation, competition and strain replacement. Bull Math Biol (2007) 0.98
Dynamic regulation of CD45 lateral mobility by the spectrin-ankyrin cytoskeleton of T cells. J Biol Chem (2010) 0.97
Effects of intracellular calcium and actin cytoskeleton on TCR mobility measured by fluorescence recovery. PLoS One (2008) 0.96
A stochastic model of latently infected cell reactivation and viral blip generation in treated HIV patients. PLoS Comput Biol (2011) 0.95
Quantification and modeling of tripartite CD2-, CD58FC chimera (alefacept)-, and CD16-mediated cell adhesion. J Biol Chem (2007) 0.94
Analysis of serial engagement and peptide-MHC transport in T cell receptor microclusters. Biophys J (2008) 0.93
An age-structured model of hiv infection that allows for variations in the production rate of viral particles and the death rate of productively infected cells. Math Biosci Eng (2004) 0.93
Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: analysis of function and distribution in lymphoid organs. J Allergy Clin Immunol (2010) 0.92
The Wiskott-Aldrich syndrome protein permits assembly of a focused immunological synapse enabling sustained T-cell receptor signaling. Haematologica (2011) 0.91
Analysis of membrane-localized binding kinetics with FRAP. Eur Biophys J (2008) 0.91
Vaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: timing is everything. BMC Public Health (2011) 0.91
The Wiskott-Aldrich syndrome protein regulates CTL cytotoxicity and is required for efficient killing of B cell lymphoma targets. J Leukoc Biol (2010) 0.89
Analysis of peptide/MHC-induced TCR downregulation: deciphering the triggering kinetics. Cell Biochem Biophys (2006) 0.86
Mechanical modulation of receptor-ligand interactions at cell-cell interfaces. Biophys J (2012) 0.86
CIP4 controls CCL19-driven cell steering and chemotaxis in chronic lymphocytic leukemia. Cancer Res (2013) 0.84
Improving parameter estimation for cell surface FRAP data. J Biochem Biophys Methods (2007) 0.83
Plasticity of immunological synapses. Curr Top Microbiol Immunol (2010) 0.82
Kinetic proofreading model. Adv Exp Med Biol (2008) 0.82
Asymptotic analysis of first passage time problems inspired by ecology. Bull Math Biol (2014) 0.81
Modeling effect of a γ-secretase inhibitor on amyloid-β dynamics reveals significant role of an amyloid clearance mechanism. Bull Math Biol (2010) 0.81
Wiskott-Aldrich syndrome protein controls antigen-presenting cell-driven CD4+ T-cell motility by regulating adhesion to intercellular adhesion molecule-1. Immunology (2012) 0.80
A theoretical and experimental study of competition between solution and surface receptors for ligand in a Biacore flow cell. Bull Math Biol (2006) 0.80
Erratum: Toll-like receptor ligands sensitize B-cell receptor signalling by reducing actin-dependent spatial confinement of the receptor. Nat Commun (2015) 0.76
A biophysical model of cell adhesion mediated by immunoadhesin drugs and antibodies. PLoS One (2011) 0.75
Current understanding of the Wiskott-Aldrich syndrome and prospects for gene therapy. Expert Rev Clin Immunol (2007) 0.75
Corrigendum to "Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott-Aldrich Syndrome in Preclinical Models". Mol Ther (2016) 0.75